Sort by
Refine Your Search
-
Profile First Stage Researcher (R1) Country France Application Deadline 10 Sep 2025 - 23:59 (UTC) Type of Contract Temporary Job Status Full-time Hours Per Week 35 Offer Starting Date 15 Oct 2025 Is the job
-
Inria, the French national research institute for the digital sciences | Villeneuve la Garenne, le de France | France | about 23 hours ago
Framework Programme? Not funded by a EU programme Reference Number 2025-09265 Is the Job related to staff position within a Research Infrastructure? No Offer Description Inria is a French institute dedicated
-
Researcher Profile First Stage Researcher (R1) Country France Application Deadline 10 Sep 2025 - 23:59 (UTC) Type of Contract Temporary Job Status Full-time Hours Per Week 35 Offer Starting Date 1 Oct 2025 Is
-
First Stage Researcher (R1) Country France Application Deadline 10 Sep 2025 - 23:59 (UTC) Type of Contract Temporary Job Status Full-time Hours Per Week 35 Offer Starting Date 1 Nov 2025 Is the job funded
-
Description of the offer : The condensed matter theory group at Institut Néel (CNRS, Grenoble) invites applications for a three-year PhD position in condensed matter physics starting from October
-
, all these theories often assume a uniform protective mechanism, without fully considering the specific adaptations of EOM myofibers. Intriguingly, EOMs contain both singly and multiply innervated fibres
-
, we will make full use of X‐ray Absorption Spectroscopy (XAS), including X‐ray Magnetic Circular Dichroism (XMCD) - an inherently element- and orbital-selective technique - alongside X‐ray diffraction
-
slicing. - Develop advanced AI/ML algorithms and data analytics techniques to automate and optimise exposure requests, adapted to available resources and real-time demand. - Propose and
-
-based leveraged microbiome management in the context of One Health. METAMIC 3 is funded by the European Commission under the Horizon Europe framework programme (Grant Agreement number 101225682
-
-year survival rate below 10%, is rising sharply in incidence, particularly in France. Environmental exposures and type 2 diabetes are under investigation for their roles in tumor initiation and